Centers for Disease Control and Prevention

Description

The purpose of this announcement is to provide support and assistance to the foreign governments of Egypt, Madagascar, Moldova, Nepal, Paraguay, Sri Lanka and Zambia to develop and implement sustainable influenza surveillance systems initiated as part of the current cooperative agreement IP09-902. The intent of this program is to provide additional support for countries that began and/or enhanced influenza surveillance networks and the systematic collection of virological and epidemiological influenza information with funding from the prior announcement. Countries are expected to develop and implement detailed plans to assume full responsibility and funding for a robust and timely routine surveillance system for seasonal, novel and pandemic influenza. The systems should have the ability for rapid detection of and response to potential pandemic influenza as well as for monitoring the occurrence and assessing the impact of seasonal influenza in the country. Countries are encouraged to focus on severe respiratory disease surveillance capacity, but are not limited to this strategy. Countries receiving funding must maintain or make progress towards having an active World Health Organization (WHO) National Influenza Center (NIC) laboratory and contribute regularly to the Global Influenza Surveillance and Response System (GISRS). Counties will be required to develop and implement a plan to phase out United States (U.S.) government financial assistance for their influenza surveillance systems over the five years of this new cooperative agreement. This will not preclude future technical collaboration once the cooperative agreements have ended or eligibility for other U.S. government sponsored FOA’s related to influenza (e.g. those related to research or influenza prevention and control policy development).

Who can apply

• Others

Contact

CDC Procurement and Grants Office <br/>(PGO) Technical Information Management Section (TIMS) <br/>Phone: 770-488-2700 <br/>E-mail: pgotim@cdc.gov <br/>
pgotim@cdc.gov